Uncontrolled Moderate to Severe
1 clinical trials · Condition
◉ Watch Uncontrolled Moderate to Severe
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma (NCT05813470) | Cinnagen | 2021-01-18 |
Track Uncontrolled Moderate to Severe automatically
Every clearance here is in the API, with alerts when new ones post.